TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.

Geoffrey R Oxnard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.